Non-invasive actionable biomarkers for metastatic prostate cancer
In the current clinical setting, many disease management options are available for men diagnosed with prostate cancer. For metastatic prostate cancer, first-line therapies almost always involve agents designed to inhibit androgen receptor (AR) signaling. Castration-resistant prostate cancers (CRPCs)...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-10-01
|
Series: | Asian Journal of Urology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388216300637 |